Immune complexes present in the sera of autoimmune mice activate rheumatoid factor B cells

Journal of Immunology

Volumn 165, Issue 3, 2000, Pages 1626-1633

  Rifkin, Ian R ^a   Leadbetter, Elizabeth A ^a   Beaudette, Britte C ^a   Kiani, Cornelia ^a   Monestier, Marc ^b   Shlomchik, Mark J ^c   Marshak Rothstein, Ann ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN G2A; RHEUMATOID FACTOR;

ALLOTYPE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BINDING AFFINITY; CELL PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; TRANSGENIC MOUSE;

EID: 0034254310     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.3.1626     Document Type: Article

References (55)

1. Nemazee, D. A., and K. Buerki. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337:562.
2. Hartley, S. B., J. Crosbie, R. Brink, A. A. Kantor, A. Basten, and C. G. Goodnow. 1991. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353:765.
3. Chen, C., Z. Nagy, M. Z. Radic, R. R. Hardy, D. Huszar, S. A. Camper, and M. Weigert. 1995. The site and stage of anti-DNA B cell deletion. Nature 373: 252.
4. Gay, D., T. Saunders, S. Camper, and M. Weigert. 1993. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177:999.
5. Tiegs, S. L., D. M. Russell, and D. Nemazee. 1993. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177:1009.
6. Goodnow, C. G., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S. Wotherspoon, R. H. Loblay, K. Raphael, et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334:676.
7. Erikson, J., M. Z. Radic, S. A. Camper, R. R. Hardy, C. Carmack, and M. Weigert. 1991. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 349:331.
8. Tsao, B. P., A. Chow, H. Cheroutre, Y. W. Song, M. E. McGrath, and M. Kronenberg. 1993. B cells are anergic in transgenic mice that express IgM anti-DNA antibodies. Eur. J. Immunol. 23:2332.
9. Hannum, L. G., D. Ni, A. M. Haberman, M. G. Weigert, and M. J. Shlomchik. 1996. A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease. J. Exp. Med. 184:1269.
10. Spatz, L., V. Saenko, A. Iliev, L. Jones, L. Geskin, and B. Diamond. 1997. Light chain usage in anti-double stranded DNA B cell subsets: role in cell fate determinations. J. Exp. Med 185:1317.
11. Mandik-Nayak, L., S. J. Seo, A. Eaton-Bassiri, D. Allmand, R. R. Hardy, and J. Erikson. 2000. Functional consequences of the developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J. Immunol. 164:1161.
12. Watanabe-Fukunaga, R., C. Brannan, N. Copeland, N. Jenkins, and S. Nagata. 1992. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediate apoptosis. Nature 356:314.
13. Takahashi, T., M. Tanaka, C. Brannan, N. Jenkins, N. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 76:969.
14. Izui, S., V. E. Kelley, K. Masuda, H. Yoshida, J. B. Roths, and E. D. Murphy. 1984. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immnnol. 133:227.
15. Cohen, P. L., and R. A. Eisenberg. 1991. lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
16. Wolfowicz, C. B., P. Sakorafas, T. L. Rothstein, and A. Marshak-Rothstein. 1988. Oligoclonality of rheumatoid factors arising spontaneously in lpr/lpr mice. Clin. Immunol. Immunopathol. 46:382.
17. Shan, H., M. J. Shlomchik, A. Marshak-Rothstein, D. P. Pisetsky, S. Litwin, and M. G. Weigert. 1994. The mechanism of autoantibody production in an autoimmune MRL/lpr mouse. J. Immunol. 153:5104.
18. Shlomchik, M. J., A. Marshak-Rothstein, C. B. Wolfowicz, T. L. Rothstein, and M. G. Weigert. 1987. The role of clonal selection and somatic mutation in autoimmunity. Nature 328:805.
19. Jacobson, B. A., J. Sharon, H. Shan, M. Shlomchik, M. G. Weigert, and A. Marshak-Rothstein. 1994. An isotype switched and somatically mutated rheumatoid factor clone isolated from a MRL-lpr/lpr mouse exhibits limited intraclonal affinity maturation. J. Immunol. 152:4489.
20. Reininger, L., T. Berney, T. Shibata, F. Spertini, R. Merino, and S. Izui. 1990. Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms. Proc. Natl. Acad. Sci. USA 87:10038.
21. Berney, T., T. Fulpius, T. Shibata, L. Reininger, J. Van Snick, H. Shan, M. Weigert, A. Marshak-Rothstein, and S. Izui. 1992. Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass. Int. Immunol. 4:93.
22. Shlomchik, M. J., D. Zharhary, S. Camper, T. Saunders, and M. Weigert. 1993. A rheumatoid factor transgenic mouse model for autoantibody regulation. Int. Immunol. 5:1329.
23. Rathmell, J. C., and C. G. Goodnow. 1994. Effects of the lpr mutation on elimination and inactivation of self-reactive B cells. J. Immunol. 153:2831.
24. Wang, H., and M. J. Shlomchik. 1999. Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice. J. Exp. Med. 190:639.
25. Dhein, J., H. Walczak, C. Baumier, K.-M. Debatim, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/Fas/CD95). Nature 373:438.
26. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, et al. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
27. Ju, S.-T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
28. Rothstein, T. L., J. K. M. Wang, D. J. Panka, L. C. Foote, Z. Wang, B. Stanger, H. Cui, S.-T. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374:163.
29. Schattner, E. J., K. B. Elkon, D. H. You, J. Tumang, P. H. Krammer, M. K. Crow, and S. M. Friedman. 1995. CD40L ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 182:1557.
30. + T cells reactivated with superantigen are both more sensitive to FasL-mediated killing and express a higher level of FasL. Cell. Immunol. 179:153.
31. Losman, M., T. M. Fasy, K. E. Novick, and M. Monestier. 1992. Monoclonal autoantibodies to subnucleosomes from a MRL/Mp-+/+ mouse. J. Immunol. 148:1561.
32. Losman, J. A., T. M. Fasy, K. E. Novick, M. Massa, and M. Monestier. 1993. Nucleosome-specific antibody from an autoimmune MRL/Mp-lpr/lpr mouse. Arthritis Rheum. 36:552.
33. Losman, J. A., T. M. Fasy, K. E. Novick, and M. Monestier. 1993. Relationships among antinuclear antibodies from autoimmune MRL mice reacting with histone H2A-H2B dimers and DNA. Int. Immunol. 5:513.
34. Monestier, M., and K. E. Novick. 1996. Specificities and genetic characteristics of nucleosome-reactive antibodies from autoimmune mice. Mol. Immunol. 33:89.
35. Bloom, D. D., J. L. Davignon, P. L. Cohen, R. A. Eisenberg, and S. H. Clarke. 1993. Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice. J. Immunol. 150:1579.
36. Perkins, D. L., J. Michaelson, and A. Marshak-Rothstein. 1987. The lpr gene is associated with resistance to engraftment by lymphoid but not erythroid stem cells from normal mice. J. Immunol. 138:466.
37. Marshak-Rothstein, A., M. Sickevitz, M. Margolies, M. Mudgett-Hunter, and M. Gefter. 1980. Hybridoma proteins expressing the predominant idiotype of the anti-azophenylarsonate response of A/J mice. Proc. Natl. Acad. Sci. USA 77: 1120.
38. Uwatoko, S., M. Mannik, I. R. Oppliger, M. Okawa-Takasuji, S. Aotsuka, R. Yokohari, G. Seki, S. Taniguchi, K. Suzuki, and K. Kurokawa. 1995. C1q-binding immunoglobulin G in MRL/I mice consists of immune complexes containing antibodies to DNA. Clin. Immunol. Immunopathol. 75:140.
39. Burlingame, R., and R. Rubin. 1990. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J. Immunol. Methods 134:187.
40. Slack, J. H., L. Hang, J. Barkley, R. J. Fulton, R. D'Hoostelaere, A. Robinson, and F. J. Dixon. 1984. Isotype of spontaneous and mitogen-induced autoantibodies in SLE-prone mice. J. Immunol. 132:1271.
41. Weintraub, J. P., V. Godfrey, P. A. Wothusen, R. L. Cheek, R. A. Eisenberg, and P. L. Cohen. 1998. Immunological and pathological consequences of mutations in both Fas and Fas ligand. Cell. Immunol. 186:8.
42. Amoura, Z., H. Chabre, S. Koutouzov, C. Lotton, A. Cabrespines, J. F. Bach, and L. Jacob. 1994. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum. 37:1684.
43. Burlingame, R., M. L. Boey, G. Starkebaum, and R. Rubin. 1994. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J. Clin. Invest. 94:184.
44. Bell, D. A., and B. Morrison. 1991. The spontaneous apoptotic death of normal human lymphocytes in vitro: the release of, and immunoproliferative response to, nucleosomes in vitro. Clin. Immunol. Immunopathol. 60:1326.
45. Xu, X., B. Press, N. M. Wagle, H. Cho, A. Wandinger-Ness, and S. K. Pierce. 1996. B cell antigen receptor signaling links biochemical changes in the class II peptide-loading compartment to enhanced processing. Int. Immunol. 8:1867.
46. Chan, P. L., and N. R. Sinclair. 1971. Regulation of the immune response. V. An analysis of the function of the Fc portion of antibody in suppression of an immune response with respect to interaction with components of the lymphoid system. Immunology 21:967.
47. Phillips, N. E., and D. C. Parker. 1984. Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. J. Immunol. 132:627.
48. Takai, T., M. Ono, M. Hikada, H. Ohmori, and J. V. Ravetch. 1996. Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature 379:346.
49. Milne, R. W., M. P. Chalon, and J. P. Vaerman. 1981. Suppression of the in vitro immune response by isolated mouse IgG subclasses. Mol. Immunol. 17:1599.
50. Phillips, N., and D. C. Parker. 1985. Subclass specificity of Fcγ receptor-mediated inhibition of mouse B cell activation. J. Immunol. 134:2835.
51. Wener, M. H., and M. Mannik. 1983. Influence of immune complex lattice on the C1q solid phase assay as determined with covalcntly cross-linked immune complexes. Clin. Exp. Immunol. 52:543.
52. Mannik, M. 1980. Physicochemical and functional relationships of immune complexes. J. Invest. Dermatol. 74:333.
53. Eisenberg, R. A., D. S. Pisetsky, S. Y. Craven, J. P. Gradier, M. A. O'Donnell, and P. L. Cohen. 1990. Regulation of the anti-Sm autoantibody response in systemic lupus erythematosus mice by monoclonal anti-Sm antibodies. J. Clin. Invest. 85:86.
54. Nemazee, D., D. Russell, B. Arnold, G. Haemmerling, J. Allison, J. F. A. P. Miller, G. Morahan, and K. Buerki. 1991. Clonal deletion of autospecific B lymphocytes. Immunol. Rev. 122:117.
55. Boes, M., T. Schmidt, K. Linkemann, B. Beaudette, A. Marshak-Rothstein, and J. Chen. 2000. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. USA 97:1184.